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Auburn, AL, USAA B S T R A C TObjectives: The purpose of this study was to explore intravenous (IV)
medication errors in a Chinese hospital. The speciﬁc objectives were to
1) explore and measure the frequency of IV medication errors by direct
observation and identify clues to their causes in Chinese hospital
inpatient wards and 2) identify the clinical importance of the errors
and ﬁnd the potential risks in the preparation and administration
processes of IV medications. Methods: A prospective study was con-
ducted by using the direct observational method to describe IV medi-
cation errors on two general surgery patient wards in a large teaching
hospital in Beijing, China. A trained observer accompanied nurses
during IV preparation rounds to detect medication errors. The differ-
ence in mean error rates between total parenteral nutrition (TPN) and
non-TPN medications was tested by using the Mann-Whitney U test.
Results: A ﬁnal total of 589 ordered IV doses plus 4 unordered IV dosesee front matter Copyright & 2015, International S
r Inc.
.1016/j.vhri.2015.03.004
st: The authors have indicated that they have no
@ferris.edu.
ndence to: Qian Ding, 220 Ferris Drive, Ferris Stateas prepared and administered to the patients was observed from August
3, 2010, to August 13, 2010. The overall error rate detected on the study
ward was 12.8%. The most frequent errors by category were wrong dose
(5.4%), wrong time (3.7%), omission (2.7%), unordered dose (0.7%), and
extra dose (0.3%). Excluding wrong time errors, the error rate was 9.1%.
Non-TPN medications had signiﬁcantly higher error rates than did TPN
medications including wrong time errors (P ¼ 0.0162). Conclusions: A
typical inpatient in a Chinese hospital was subject to about one IV error
every day. Pharmacists had a very limited role in ensuring the accuracy
of IV medication preparation and administration processes.
Keywords: direct observation, intravenous, high-alert medications,
medication errors.
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Outcomes Research (ISPOR). Published by Elsevier Inc.Background
The medication use system for inpatients in hospitals usually
contains prescribing, transcribing, dispensing, administration,
and monitoring steps. The perspective of the medication use
system for health care providers was to collaboratively promote
efforts to achieve optimal therapeutic goals and encourage the
enhancement of highly reliable and high-quality care [1,2].
Intravenous (IV) medication preparation is a very complex
process including multiple steps: the selection of correct drugs,
the dissolving of powder, and the transfer of injectable ﬂuid from
the original vial or ampoule into a base solution infusion bag [3].
Medication errors may be introduced during any of these steps of
this complex process. IV medications are considered to be
particularly dangerous because they usually go directly into the
patient’s vein via infusion, with immediate onset of systemic
effects, low therapeutic index of many IV medications, and thedifﬁculty of reversing the pharmacologic effects after IV admin-
istration [4,5].
Although errors can happen at any stage of the medication
use system, the ultimate outcome of the medication use system
from the patient’s perspective is the rate of errors that actually
reach the patient at the point of administration [6]. Many
methods were used to capture medication errors, including direct
observation, chart review, incident report, and so forth [7]. The
direct observation method, which was developed by Barker and
McConnell [8] in 1962, was conﬁrmed to be able to detect more
medication errors than did the other two methods: chart review
and incident report [9]. Studies using the direct observational
method found that error rates of IV medications admixed by
nurses in hospitals varied largely from 26.9% to 49% in Europe
[10–16]. Using the direct observation method, Flynn et al. [17]
reported that the mean error rate of IV admixture compounding
at ﬁve US hospital pharmacies was 9% [17].ociety for Pharmacoeconomics and Outcomes Research (ISPOR).
conﬂicts of interest with regard to the content of this article.
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countries. In 2009, China used 10.4 billion infusion bottles
annually [18]. This number of infusions was equivalent to
approximately eight infusion bottles per capita for 1.3 billion
Chinese people, much higher than the estimated three infusion
bottles per capita at the international level [18]. Given that life-
threatening IV medication error cases have been reported
recently, the study of IV medication errors in Chinese hospitals
is still rare [19,20]. If the error rate of 9% was applied to the
Chinese hospitals in which IV infusions were administered, about
900 million errors involving IV infusions would have occurred
annually in these hospitals.
The ﬁrst objective of this study was to explore and measure
the frequency of IV medication errors by direct observation and
identify clues to their causes in Chinese hospital inpatient wards.
The second objective was to identify the clinical importance of
the errors and ﬁnd potential risks in existing preparation and
administration processes of IV medications.Research Methods
Operational Deﬁnitions
An IV medication error was deﬁned as any ingredient observed that
was mixed in the IV bag and administered to the patients
different from the interpretable physician’s orders written on
the patient charts. Total opportunities for error (TOEs) were deﬁned
as the IV ingredient doses ordered by the physician and inter-
pretable by the observer, plus unordered IV ingredient doses
observed to be given to the patient. The detected medication
errors were divided by the TOEs and multiplied by 100 to obtain
the medication error rate.
The IV medication errors were classiﬁed into the six catego-
ries listed below:1. An unordered drug error: A dose that was not ordered for the
patient was added in the IV solution and administered to the
patient.2. An omission error: An ingredient was not mixed in the IV
solution and administered to the patient.3. A wrong dose error: An ingredient was given more than 10%
volume and concentration greater or less than the correct
dosage, in the judgment of the observer.4. An extra dose error: An ingredient dose given in excess of the
total number of times ordered by the physician, such as an
ingredient dose injected in the IV solution and given to the
patient on the basis of an expired order, after a drug has been
discontinued, or after an ingredient dose has been put
on hold.5. A wrong time error: The mixed IV solution was delivered more
than 60 minutes before or after the scheduled administration
time.6. A wrong route error: The mixed IV solution was administered
via a different location or site on the patient’s body than was
ordered.
The criterion for judging potential clinical importance was
appearance in ISMP’s list of high-alert medications in 2008 [21].
Study Site
The research protocol was approved by the hospital site in March
2010 and by the Institutional Review Board at Auburn University
in May 2010. Two general (gastrointestinal) surgery patient wards
at a teaching hospital with more than 1000 beds in Beijing were
offered by the hospital as a convenience sample. The patient
wards with 53 beds housed 50% of cancer patients, served by 13physicians and 18 employed nurses. Most (90%) of the prescrip-
tions for the patients on wards were IV medications. No clinical
pharmacist was currently assigned to the wards.
A new Hospital Information System (HIS), an electronic
prescribing system, was installed for inpatients in the hospital
in July 2010. Physicians prescribed medications both in the
computerized HIS and in the patient charts (handwritten). A
medical nurse sent the medication orders through the HIS to the
central pharmacy in the hospital after checking the consistency
of medication orders between the HIS and the patient charts. Oral
medications were supplied as unit doses and IV medications
were dispensed in a bulk form to the wards once a day by the
central pharmacy. The medical nurses transcribed handwritten
medication orders to the medication inspection sheet for each
patient. IV medications, including total parenteral nutrition (TPN)
medications and non-TPN medications, were prepared by med-
ical nurses in an IV preparation room.
TPN medications, which were usually given peripherally once
daily, contained multiple additives such as vitamin C injection,
sodium chloride injection concentrate (10%), compound amino
acid injection (15-HBC) 250 ml, and so forth in the Kabiven TM PI
fat emulsion bag (1440 ml). The TPN doses were placed on the
counter aligned with the transcribed medication inspection sheet
for each patient by an auxiliary worker. The medical nurses
prepared TPN doses by injecting the prescribed volume of
additives (lipids, protein, electrolytes, glucose, etc.) into the
Kabiven TM PI fat emulsion bag. The patient’s name and the
bed number were written on the label using a marker pen on the
Kabiven TM PI fat emulsion bag after the admixture process was
completed.
Non-TPN medications usually contained one additive such as
an antibiotic in a base solution of 5% glucose (250 ml) or 0.9%
sodium chloride (100 ml). The handwritten label on the base
solution bag included the name/volume of the ingredient and the
administration time. No patient information was included on the
label. The nurse injected the volume of the additive into the base
solution and mixed them as an assembly line. The patient’s
name and the bed number were handwritten on the label when
the nurses administered the non-TPN medications at the
patient’s bedside.
Data Collection Procedures
The direct observation method was used by a PhD candidate from
the Department of Pharmacy Care Systems at Auburn University
to detect IV medication errors. The observer was trained and
certiﬁed in the direct observation method at the East Alabama
Medical Center by Dr. Elizabeth Flynn in July 2008. Both prepara-
tion and administration processes were observed to detect wrong
dose errors that may have occurred at the preparation process,
but only medication administration errors were considered as the
outcome at the end point of the medication use system.
The observer randomly picked up a nurse who prepared the IV
medications and recorded the information of the admixing.
When the nurse administered the IV medications to the patients,
the observer accompanied the nurse as she delivered and
administered the IV bags at the bedside. The observer recorded
the information of the patient and the time and the label
information on the IV bags administered. The observer’s notes
for preparation and administration processes were combined for
each patient and later compared with the physician’s orders for
discrepancies.
The nurses who were 18 years or older were regularly
employed for more than 1 year at the study site and regularly
prepared and administered IV medications. The nurses provided
their consent for observation. After the observed nurses were
initially told the purpose of the study, the term “medication
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participants were told that they could withdraw from the study at
any time. The observed nurses were asked not to change any of
their normal routines and to continue their normal working
performance during the observation. Conﬁdentiality was pro-
tected by coding the names of the nurses and the patients.
The sample was deﬁned as the observed IV component doses
that were ordered, prepared, and administered for the patients
on the general surgery patient wards.
Statistical Analyses
Descriptive data of IV medication error rates including the
number of errors for each error category, TOEs, and error rates
were provided for each observation day. The difference in the
distributions of error rates between TPN and non-TPN medica-
tions was tested by using the Mann-Whitney U test. A P-value of
less than 0.05 was used to represent statistical signiﬁcance. SAS
software, Version 9.2 (SAS, Inc., Cary, NC), was used in statistical
analysis.Results
A ﬂow chart of the current IV medication distribution system for
inpatients on the gastrointestinal surgical patient wards is dis-
played in Fig. 1. The workﬂow chart shows that the pharmacists
had a very limited role in ensuring the accuracy of IV medication
preparation and administration processes.
The observations were performed in a nonjudgmental and
unobtrusive way from August 3, 2010, to August 13, 2010. Day
shifts from 8 AM to 3 PM were chosen for observation because of
the high volume of IV administration doses. The principal
investigator excluded 7 doses from the TOEs as falling outsideFig. 1 – IV medication distribution system for inpatients in a Chinof the operational deﬁnitions. A ﬁnal total of 589 ordered doses
plus 4 unordered doses as prepared and administered to the
patients were observed from August 3, 2010, to August 13, 2010.
The overall IV medication error rate detected on the study
wards in a Chinese hospital was 12.8% (76 errors of 593 TOEs).
The range was 6.0% to 16.7%, with a 95% conﬁdence interval of
2.0% (see Fig. 1). Excluding wrong time errors, the error rate was
9.1%. The error types by category demonstrating the most
frequent errors were wrong dose (5.4%), wrong time (3.7%),
omission (2.7%), unordered dose (0.7%), and extra dose (0.3%);
as a percentage of all errors, the results included wrong dose
(42%), wrong time (29%), omission (21%), unordered dose (5%),
and extra dose (3%) (Table 1).
The IV medications were prepared by the same group of
nurses on rotation. Non-TPN medications were prepared by one
nurse, whereas TPN medications were prepared by two nurses in
the same IV preparation room. Non-TPN medications (60 errors
out of 397 TOEs) had signiﬁcantly higher error rates than did TPN
medications (16 errors out of 196 TOEs) including wrong time
errors (P ¼ 0.0162) (Fig. 2). The mean error rates by category
between TPN medications and non-TPN medications were com-
pared (Table 2). Excluding wrong time errors, there was no
signiﬁcant difference in the distributions of error rates between
TPN medications and non-TPN medications (P ¼ 0.3271) (Table 3).
Examples of TPN and non-TPN medication errors are provided in
Tables 4 and 5.
Among 16 TPN dose errors, 81% of the errors (13 errors)
involved ISMP’s high-alert medications, including insulin, potas-
sium chloride for injection concentrate, and sodium chloride for
injection concentrate. These errors should be taken into consid-
eration because of their potentially signiﬁcant clinical conse-
quences. Among the errors involving high-alert medications,
insulin errors occurred at the rate of 4% (7 errors out of 196
TOEs). For potassium chloride for injection concentrate andese hospital. IV, intravenous; TPN, total parenteral nutrition.
Table 1 – Intravenous medication error rates by observational day.
Error category Date: August 3–13, 2010 Overall
Day
1
Day
2
Day
3
Day
4
Day
5
Day
6
Day
7
Day
8
Day
9
Day
10
Day
11
Omission 4 1 0 3 0 1 0 0 5 2 0 16
Unordered dose 2 0 0 0 0 0 0 0 2 0 0 4
Wrong dose 2 3 6 3 2 1 2 5 3 4 1 32
Extra dose 0 0 0 2 0 0 0 0 0 0 0 2
Wrong time 0 0 0 0 3 2 4 4 3 2 4 22
Wrong route 0 0 0 0 0 0 0 0 0 0 0 0
Total number of
errors
8 4 6 8 5 4 6 9 13 8 5 76
TOEs * 69 67 41 55 42 37 42 58 78 61 43 593
Error rate (%)† 11.6 6.0 14.6 14.5 11.9 10.8 14.3 15.5 16.7 13.1 11.6 12.8
IV, intravenous.
* TOEs, total opportunities for error were deﬁned as the IV component doses ordered by the physician and interpretable by the observer, plus
unordered IV ingredient doses observed to be given to the patient.
† Error rate ¼ (total number of errors/TOEs)  100%.
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errors out of 196 TOEs) and 1% (2 errors out of 196 TOEs),
respectively. Both potassium chloride for injection concentrate
and sodium chloride for injection concentrate are important for
the maintenance of the body’s ﬂuid and electrolyte balance. The
errors involving electrolyte drugs can cause electrolyte imbal-
ance, extravasation, or heart arrest.Discussion
This study used the direct observation method for measuring the
incidence of IV medication errors and found that the IV medi-
cation error rate was 9.1%, excluding wrong time errors. Each
patient received about 10 doses per day, and each patient faced
about one error every day. An observation study of errors in IV
admixture compounding at ﬁve large hospital pharmaciesFig. 2 – Distribution difference of medication error rates betwee
nutrition.detected an error rate of 9% (147 errors per 1679 doses), with
the most common type of error being wrong dose [17].
A similar study by Taxis and Barber [15] suggested that IV drug
errors can be reduced by the involvement of the clinical pharma-
cists as the key health professionals in ward practice, removing
the nurses from the task of preparing the IV drugs, restricting the
supply and stock of concentrated potassium chloride on ward,
and including the central preparation of IV medications. A
Council of Europe report attributed these IV errors to the lack of
unit-dose injectable medications and insufﬁcient pharmacy staff-
ing resources [22].
A unit dose–based centralized Pharmacy Intravenous Admix-
ture Center Service preparing TPNs was installed in this hospital
1 year after the study to improve patient safety. In the new
system, a pharmacist checks the orders for the compounding
session and prints out the TPN mixture labels. TPN mixture
labels, which were printable and ready to stick on the infusion
bag, contained patient’s and prescription information as well asn TPN and non-TPN medications. TPN, total parenteral
Table 2 – Mean error rates by error category and medication type.
Error category Mean error rate, % (SD) P-value*
Overall medications TPN medications Non-TPN medications
Omission 2.3 (2.6) 2.3 (5.3) 2.1 (3.3) 0.5581
Unordered dose 0.5 (1.1) 0.7 (2.3) 0.3 (1.0) 0.9475
Wrong dose 5.6 (3.5) 3.9 (3.5) 8.8 (13.9) 0.1844
Extra dose 0.3 (1.1) 0 (0) 0.5 (1.7) 0.3173
Wrong time 4.1 (3.8) 0 (0) 6.0 (5.8) 0.0022†
SD, standard deviation; TPN, total parenteral nutrition.
* P values are for the comparison of distribution difference error rates between TPN and non-TPN medications.
† P o 0.01.
Table 3 – Difference in medication error rates between TPN and non-TPN medications by error category.
Group N Rank average Sum of ranks U Z P-value*
TPN medications 11 12.9 142 45 0.985 0.3271
Non-TPN medications 11 10.1 111
TPN, total parenteral nutrition.
* P-value is for the comparison of error rate distributions between TPN and non-TPN medications.
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tion of insulin could not be placed unless the exact dose of
insulin was entered in the computer. The dosage of insulin was
printed on the IV mixture labels, and no further calculation was
therefore needed by nurses during the admixture procedure.
Assistants ﬁlled baskets for each preparation with the needed
TPN ingredients and labels. TPNs for each patient were processed
as individual compounding and mixed by an individual in the
compounding hood. Especially high-risk medications, narcotics,
and sound-alike and look-alike medications were under central-
ized management in the pharmacy. Hospitals with the Pharmacy
Intravenous Admixture Center Service have increased from 19%
(9 of 47 hospitals) in 2009 to 27% (16 of 59 hospitals) in 2011 in the
Beijing area based on survey results [23,24].
In this study, the range of errors of wrong dosage of insulin
was 40% to 100%, with a prevalence of underdosing. The patient
was at the risk for hypoglycemia when overdosing insulin,Table 4 – Examples of TPN medication errors.
TPN order, once daily
Potassium chloride injection concentrate (15%), 10 ml Potassium c
Potassium chloride injection concentrate (15%), 10 ml Potassium c
Potassium chloride injection concentrate (15%), 30 ml Potassium c
Ratio of insulin to glucose 1:2.5
Ratio of insulin to glucose 1:4
None Sodium ch
None
Ratio of insulin to glucose 1:5
Vitamin K1 20 mg
Vitamin C 3 g (7.5 ml)
TPN, total parenteral nutrition.hyperglycemia when underdosing or omitting insulin, or compli-
cations due to either hypoglycemia or hyperglycemia. The Joint
Commission on Accreditation of Healthcare Organizations con-
sidered insulin to be one of the top three “high-risk medications”
in the inpatient setting [21]. Hellman [25] found that 33% of the
medical errors that caused death within 48 hours of the error
involved insulin therapy and administration in the care of a
hospitalized patient.
Limitations of this study should be noted. The two patient
wards were selected as a convenience sample in a large 3A level
teaching hospital in Beijing, the capital of China. The Chinese
hospital accreditation system starting in 1989 was reset in 2011
with a cycle of every 4 years by the Ministry of Health [26]. This
system deﬁnes three hospital grades (3, 2, and 1, with the higher
number meaning a higher level of the hospital) on the basis of
infrastructure and administrative level and three within-grade
levels (A, B, and Fail) on the basis of an evaluation by a committeeDose given Error category
hloride injection concentrate (15%),
8 ml
Wrong dose
hloride injection concentrate (15%),
30 ml
Wrong dose
hloride injection concentrate (15%),
20 ml
Wrong dose
Insulin 0.6 ml Wrong dose (correct dose:
1 ml)
Insulin 0.6 ml Wrong dose (correct dose:
1.4 ml)
loride injection concentrate (10%),
20 ml
Unordered dose
Vitamin C 2 g (5 ml) Unordered dose
None Omission
None Omission
None Omission
Table 5 – Examples of non-TPN medication errors.
Non-TPN order Dose given Error category
Compound glycyrrhizin injection 60 ml, added in 0.9%
sodium chloride solution 250 ml, once daily
Compound glycyrrhizin injection 60 ml was
added in 0.9% sodium chloride solution 200 ml
Wrong dose
Compound glycyrrhizin injection 60 ml, added in 0.9%
sodium chloride solution 250 ml, once daily
Compound glycyrrhizin injection 45 ml was
added in 0.9% sodium chloride solution 230 ml
2 Wrong doses
Compound glycyrrhizin injection 60 ml, added in 0.9%
sodium chloride solution 250 ml, once daily
Compound glycyrrhizin injection 60 ml was
added in 0.9% sodium chloride solution 200 ml
Wrong dose
Ambroxol hydrochloride injection 60 mg, twice a day Ambroxol hydrochloride injection 4 ml (30 mg)
was given to the patient
Wrong dose
Tiopronin for injection 2 ml, added in 0.9% sodium
chloride solution 250 ml, once daily
None 2 Omissions
None 0.9% Sodium chloride solution 250 ml with
sodium aescinate for injection 20 mg was
delivered to the patient’s bed
2 Unordered
doses
Sodium aescinate for injection 20 mg, added in 0.9%
sodium chloride solution 250 ml, once daily
None 2 Omissions
Ambroxol hydrochloride injection 30 mg, twice a day
(9 AM)
None Omission
Flurbiprofen axetil injection 100 mg, added in 0.9%
sodium chloride solution 100 ml, once daily
(discontinued)
0.9% Sodium chloride solution 100 ml with
ﬂurbiprofen axetil injection 100 mg was given to
the patient
2 Extra doses
TPN, total parenteral nutrition.
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of criteria, including diagnosis information of discharged
patients, hospital administrative management, patient safety,
and service quality, and the criteria by the local health bureau
[26,27]. The statistical data from the Ministry of Health in 2012
showed that Beijing has 550 hospitals (51 third-level hospitals, 89
second-level hospitals, and 348 ﬁrst-level hospitals), which is 3%
of the total hospitals in China [28]. Therefore, the generalization
of the results from this hospital to other hospitals of different
levels in other provinces may be limited.
Only one observer was assigned in the small IV preparation
room during a busy time considering economic and space factors.
Therefore, no extra training and measurement for the agreement
of the operational deﬁnitions was necessary. A statistical difference
in error rates over the observational days was not found, meaning
that the “Hawthorne Effect” (the tendency that the subjects work
nervously and poorly or perform better when they are under
observation in an experiment) was not found in the study.Conclusions
The workﬂow chart revealed that pharmacists had a very limited
role in ensuring the accuracy of IV medication preparation and
administration processes, as well as in providing professional
knowledge to the patients. Nurses were fully responsible for the
transcription, preparation, and administration of IV medications.
During the observational period, the nurses were either
unaware of the existence of the errors or they were aware
without reporting because they did not think the errors were
serious in nature. The ﬁndings of this study suggest that it is
necessary to engage pharmacists in the IV dose preparation and
administration processes.
Deﬁciencies in the nursing IV preparation procedure that
could contribute to errors were as follows: 1) limited space when
placing all TPN ingredients for each patient closely as an
assembly line on the counter at one time, which may increase
possibilities that one patient’s doses were mixed with those for
the adjacent patient; 2) no special precautions were observed
when the nurses admixed high-risk drugs; and 3) no labelscontaining the patient information and the component drug
information were placed on the base solution bag. Such a system
lacking labels seemed likely to raise the risk of errors and make
them difﬁcult to be detected in the system especially during the
preparation process.
The results showed that IV medication errors were common
for these inpatients in this Chinese hospital, occurring in 12.8% of
the cases. Excluding wrong time errors, the error rate was 9.1%.
Assuming that each patient received about 10 doses per day, such
a patient was subject to about one error every day. If wrong time
errors were excluded, non-TPN medications had error rates
similar to those of TPN medications.Acknowledgments
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